The mortality rate from cervix uteri malignant neoplasms in Brazil showed a steady increase in the forecast period from 2024 through 2028, starting at 6.3 per hundred thousand women in 2024, gradually rising to 6.5 by 2028. This represents a consistent upward trend over these five years.
Year-on-year, the mortality rate increases slightly, indicative of a continuous public health challenge in combating this type of cancer. However, the lack of significant annual variation suggests a stable but slow growth pattern in mortality rates.
The 5-year compound annual growth rate (CAGR) provides further insight, pointing to a slight but steady average annual increase over this forecast period.
Future trends to watch include potential impacts of healthcare interventions such as increased HPV vaccination coverage and improved cervical cancer screening programs, which could alter this trajectory. Monitoring advancements in treatment options and accessibility will be crucial in the coming years to better understand their effect on mortality rates.
